Global Genetic Virus Vector Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Genetic Virus Vector Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Retroviral Vectors
  • 1.2.3 Adenoviral Vectors
  • 1.2.4 Adeno-Associated Viral Vectors
  • 1.2.5 Other
• 1.3 Market by Application
  • 1.3.1 Global Genetic Virus Vector Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Gene Therapy
  • 1.3.3 Vaccinology
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Genetic Virus Vector Market Perspective (2016-2027)
• 2.2 Genetic Virus Vector Growth Trends by Regions
  • 2.2.1 Genetic Virus Vector Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Genetic Virus Vector Historic Market Share by Regions (2016-2021)
  • 2.2.3 Genetic Virus Vector Forecasted Market Size by Regions (2022-2027)
• 2.3 Genetic Virus Vector Industry Dynamic
  • 2.3.1 Genetic Virus Vector Market Trends
  • 2.3.2 Genetic Virus Vector Market Drivers
  • 2.3.3 Genetic Virus Vector Market Challenges
  • 2.3.4 Genetic Virus Vector Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Genetic Virus Vector Players by Revenue
  • 3.1.1 Global Top Genetic Virus Vector Players by Revenue (2016-2021)
  • 3.1.2 Global Genetic Virus Vector Revenue Market Share by Players (2016-2021)
• 3.2 Global Genetic Virus Vector Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Genetic Virus Vector Revenue
• 3.4 Global Genetic Virus Vector Market Concentration Ratio
  • 3.4.1 Global Genetic Virus Vector Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Genetic Virus Vector Revenue in 2020
• 3.5 Genetic Virus Vector Key Players Head office and Area Served
• 3.6 Key Players Genetic Virus Vector Product Solution and Service
• 3.7 Date of Enter into Genetic Virus Vector Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Genetic Virus Vector Breakdown Data by Type

• 4.1 Global Genetic Virus Vector Historic Market Size by Type (2016-2021)
• 4.2 Global Genetic Virus Vector Forecasted Market Size by Type (2022-2027)

5 Genetic Virus Vector Breakdown Data by Application

• 5.1 Global Genetic Virus Vector Historic Market Size by Application (2016-2021)
• 5.2 Global Genetic Virus Vector Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Genetic Virus Vector Market Size (2016-2027)
• 6.2 North America Genetic Virus Vector Market Size by Type
  • 6.2.1 North America Genetic Virus Vector Market Size by Type (2016-2021)
  • 6.2.2 North America Genetic Virus Vector Market Size by Type (2022-2027)
  • 6.2.3 North America Genetic Virus Vector Market Size by Type (2016-2027)
• 6.3 North America Genetic Virus Vector Market Size by Application
  • 6.3.1 North America Genetic Virus Vector Market Size by Application (2016-2021)
  • 6.3.2 North America Genetic Virus Vector Market Size by Application (2022-2027)
  • 6.3.3 North America Genetic Virus Vector Market Size by Application (2016-2027)
• 6.4 North America Genetic Virus Vector Market Size by Country
  • 6.4.1 North America Genetic Virus Vector Market Size by Country (2016-2021)
  • 6.4.2 North America Genetic Virus Vector Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Genetic Virus Vector Market Size (2016-2027)
• 7.2 Europe Genetic Virus Vector Market Size by Type
  • 7.2.1 Europe Genetic Virus Vector Market Size by Type (2016-2021)
  • 7.2.2 Europe Genetic Virus Vector Market Size by Type (2022-2027)
  • 7.2.3 Europe Genetic Virus Vector Market Size by Type (2016-2027)
• 7.3 Europe Genetic Virus Vector Market Size by Application
  • 7.3.1 Europe Genetic Virus Vector Market Size by Application (2016-2021)
  • 7.3.2 Europe Genetic Virus Vector Market Size by Application (2022-2027)
  • 7.3.3 Europe Genetic Virus Vector Market Size by Application (2016-2027)
• 7.4 Europe Genetic Virus Vector Market Size by Country
  • 7.4.1 Europe Genetic Virus Vector Market Size by Country (2016-2021)
  • 7.4.2 Europe Genetic Virus Vector Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Genetic Virus Vector Market Size (2016-2027)
• 8.2 Asia-Pacific Genetic Virus Vector Market Size by Type
  • 8.2.1 Asia-Pacific Genetic Virus Vector Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Genetic Virus Vector Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Genetic Virus Vector Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Genetic Virus Vector Market Size by Application
  • 8.3.1 Asia-Pacific Genetic Virus Vector Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Genetic Virus Vector Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Genetic Virus Vector Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Genetic Virus Vector Market Size by Region
  • 8.4.1 Asia-Pacific Genetic Virus Vector Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Genetic Virus Vector Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Genetic Virus Vector Market Size (2016-2027)
• 9.2 Latin America Genetic Virus Vector Market Size by Type
  • 9.2.1 Latin America Genetic Virus Vector Market Size by Type (2016-2021)
  • 9.2.2 Latin America Genetic Virus Vector Market Size by Type (2022-2027)
  • 9.2.3 Latin America Genetic Virus Vector Market Size by Type (2016-2027)
• 9.3 Latin America Genetic Virus Vector Market Size by Application
  • 9.3.1 Latin America Genetic Virus Vector Market Size by Application (2016-2021)
  • 9.3.2 Latin America Genetic Virus Vector Market Size by Application (2022-2027)
  • 9.3.3 Latin America Genetic Virus Vector Market Size by Application (2016-2027)
• 9.4 Latin America Genetic Virus Vector Market Size by Country
  • 9.4.1 Latin America Genetic Virus Vector Market Size by Country (2016-2021)
  • 9.4.2 Latin America Genetic Virus Vector Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Genetic Virus Vector Market Size (2016-2027)
• 10.2 Middle East & Africa Genetic Virus Vector Market Size by Type
  • 10.2.1 Middle East & Africa Genetic Virus Vector Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Genetic Virus Vector Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Genetic Virus Vector Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Genetic Virus Vector Market Size by Application
  • 10.3.1 Middle East & Africa Genetic Virus Vector Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Genetic Virus Vector Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Genetic Virus Vector Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Genetic Virus Vector Market Size by Country
  • 10.4.1 Middle East & Africa Genetic Virus Vector Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Genetic Virus Vector Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 FUJIFILM Diosynth Biotechnologies U.S.A.
  • 11.1.1 FUJIFILM Diosynth Biotechnologies U.S.A. Company Details
  • 11.1.2 FUJIFILM Diosynth Biotechnologies U.S.A. Business Overview
  • 11.1.3 FUJIFILM Diosynth Biotechnologies U.S.A. Genetic Virus Vector Introduction
  • 11.1.4 FUJIFILM Diosynth Biotechnologies U.S.A. Revenue in Genetic Virus Vector Business (2016-2021)
  • 11.1.5 FUJIFILM Diosynth Biotechnologies U.S.A. Recent Development
• 11.2 Sanofi
  • 11.2.1 Sanofi Company Details
  • 11.2.2 Sanofi Business Overview
  • 11.2.3 Sanofi Genetic Virus Vector Introduction
  • 11.2.4 Sanofi Revenue in Genetic Virus Vector Business (2016-2021)
  • 11.2.5 Sanofi Recent Development
• 11.3 Lonza
  • 11.3.1 Lonza Company Details
  • 11.3.2 Lonza Business Overview
  • 11.3.3 Lonza Genetic Virus Vector Introduction
  • 11.3.4 Lonza Revenue in Genetic Virus Vector Business (2016-2021)
  • 11.3.5 Lonza Recent Development
• 11.4 Merck KGaA
  • 11.4.1 Merck KGaA Company Details
  • 11.4.2 Merck KGaA Business Overview
  • 11.4.3 Merck KGaA Genetic Virus Vector Introduction
  • 11.4.4 Merck KGaA Revenue in Genetic Virus Vector Business (2016-2021)
  • 11.4.5 Merck KGaA Recent Development
• 11.5 GENERAL ELECTRIC COMPANY
  • 11.5.1 GENERAL ELECTRIC COMPANY Company Details
  • 11.5.2 GENERAL ELECTRIC COMPANY Business Overview
  • 11.5.3 GENERAL ELECTRIC COMPANY Genetic Virus Vector Introduction
  • 11.5.4 GENERAL ELECTRIC COMPANY Revenue in Genetic Virus Vector Business (2016-2021)
  • 11.5.5 GENERAL ELECTRIC COMPANY Recent Development
• 11.6 Oxford BioMedica
  • 11.6.1 Oxford BioMedica Company Details
  • 11.6.2 Oxford BioMedica Business Overview
  • 11.6.3 Oxford BioMedica Genetic Virus Vector Introduction
  • 11.6.4 Oxford BioMedica Revenue in Genetic Virus Vector Business (2016-2021)
  • 11.6.5 Oxford BioMedica Recent Development
• 11.7 Spark Therapeutics, Inc.
  • 11.7.1 Spark Therapeutics, Inc. Company Details
  • 11.7.2 Spark Therapeutics, Inc. Business Overview
  • 11.7.3 Spark Therapeutics, Inc. Genetic Virus Vector Introduction
  • 11.7.4 Spark Therapeutics, Inc. Revenue in Genetic Virus Vector Business (2016-2021)
  • 11.7.5 Spark Therapeutics, Inc. Recent Development
• 11.8 uniQure N.V.
  • 11.8.1 uniQure N.V. Company Details
  • 11.8.2 uniQure N.V. Business Overview
  • 11.8.3 uniQure N.V. Genetic Virus Vector Introduction
  • 11.8.4 uniQure N.V. Revenue in Genetic Virus Vector Business (2016-2021)
  • 11.8.5 uniQure N.V. Recent Development
• 11.9 FinVector Vision Therapies
  • 11.9.1 FinVector Vision Therapies Company Details
  • 11.9.2 FinVector Vision Therapies Business Overview
  • 11.9.3 FinVector Vision Therapies Genetic Virus Vector Introduction
  • 11.9.4 FinVector Vision Therapies Revenue in Genetic Virus Vector Business (2016-2021)
  • 11.9.5 FinVector Vision Therapies Recent Development
• 11.10 Brammer Bio
  • 11.10.1 Brammer Bio Company Details
  • 11.10.2 Brammer Bio Business Overview
  • 11.10.3 Brammer Bio Genetic Virus Vector Introduction
  • 11.10.4 Brammer Bio Revenue in Genetic Virus Vector Business (2016-2021)
  • 11.10.5 Brammer Bio Recent Development
• 11.11 Cell and Gene Therapy Catapult
  • 11.11.1 Cell and Gene Therapy Catapult Company Details
  • 11.11.2 Cell and Gene Therapy Catapult Business Overview
  • 11.11.3 Cell and Gene Therapy Catapult Genetic Virus Vector Introduction
  • 11.11.4 Cell and Gene Therapy Catapult Revenue in Genetic Virus Vector Business (2016-2021)
  • 11.11.5 Cell and Gene Therapy Catapult Recent Development
• 11.12 Cobra Biologics
  • 11.12.1 Cobra Biologics Company Details
  • 11.12.2 Cobra Biologics Business Overview
  • 11.12.3 Cobra Biologics Genetic Virus Vector Introduction
  • 11.12.4 Cobra Biologics Revenue in Genetic Virus Vector Business (2016-2021)
  • 11.12.5 Cobra Biologics Recent Development
• 11.13 REGENXBIO Inc.
  • 11.13.1 REGENXBIO Inc. Company Details
  • 11.13.2 REGENXBIO Inc. Business Overview
  • 11.13.3 REGENXBIO Inc. Genetic Virus Vector Introduction
  • 11.13.4 REGENXBIO Inc. Revenue in Genetic Virus Vector Business (2016-2021)
  • 11.13.5 REGENXBIO Inc. Recent Development
• 11.14 Kaneka Eurogentec S.A.
  • 11.14.1 Kaneka Eurogentec S.A. Company Details
  • 11.14.2 Kaneka Eurogentec S.A. Business Overview
  • 11.14.3 Kaneka Eurogentec S.A. Genetic Virus Vector Introduction
  • 11.14.4 Kaneka Eurogentec S.A. Revenue in Genetic Virus Vector Business (2016-2021)
  • 11.14.5 Kaneka Eurogentec S.A. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer